The team at MassDevice.com and Drug Delivery Business News will be updating this post periodically as news comes out of ACC 2017, the annual American College of Cardiology meeting in Washington March 17-19. Abbott touts reduced HF rehospitalizations in MitraClip study Abbott (NYSE:ABT) released 1-year outcomes from the largest study to-date of real-world experiences […]
ACC 2017
Boston Scientific touts U.K. nod for EnduraLife batteries
Boston Scientific (NYSE:BSX) said yesterday that a U.K. healthcare agency backed its EnduraLife batteries for cardiac resynchronization therapy defibrillators, citing the savings offering by reduced replacement procedures. The guidance from Great Britain’s National Institute for Health & Care Excellence concluded that the EnduraLife technology would improve outcomes and create some $7.4 million (£6 million) in savings over 5 […]